Narjust Florez: The 6th Annual Precision Medicine Symposium, An Illustrated Tumor Board
Narjust Florez, Thoracic Medical Oncologist at the Dana-Farber Cancer Center, shared a post on X:
“The 6th Annual Precision Medicine Symposium: An Illustrated Tumor Board.
A 2-day live conference that will provide expert guidance on how to apply precision medicine approaches into real-world practice for patients with solid tumors and hematologic malignancies.”
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.
In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023